UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Study to Test the Drug EGEN-001 in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer that has Re-Grown or not Responded
    David Bender
  2. Study for Women with Node-Positive or High Risk Node Negative HER2-Low Invasive Breast Cancer
    Mark Karwal
  3. Inflammation versus Tumor: Methods to Improve Accuracy of Post-Radiotherapy PET scans in Head and Neck Cancer Patients
    Carryn Anderson
  4. Autism Research Registry
    Thomas Wassink
  5. Study to Test the Safety, Dose, and Effectiveness of ABT-888
    David Bender
  6. Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Mucositis Pain and Function (40)
    Jennifer Lee
  7. A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy and Chemotherapy in Children with ...
    Ayman El-Sheikh
  8. Clinical Trial Readiness for the Dystroglycanopathies
    Katherine D. Mathews
  9. Brain Connectivity in Adolescents
    Beng Choon Ho
  10. Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (VAMC)
    Daniel Vaena
  11. Study Patients with Advanced or Metastatic Untreated Soft Tissue Sarcoma
    Mohammed Milhem
  12. Antimullerian Hormone Levels in Girls and Adolescents Receiving Gonadotoxic Cancer Therapies
    Barbara Stegmann
  13. A multicenter, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with 177Lu-DOTA0-Tyr3-Octreotate to...
    David Bushnell
  14. Medamacs: The Medical Arm of Mechanical Circulatory Support
    Linda Cadaret
  15. A Phase II Evaluation of Ixabepilone (IND #59699, NSC #710428) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus
    David Bender
  16. Transfusion of Prematures (TOP) Trial
    Edward F. Bell
  17. A Phase II Evaluation of SU11248 (Sunitinib Malate) (IND #74019, NSC #736511) in the Treatment of Persistent or Recurrent Clear Cell Ovarian Carcinoma
    David Bender
  18. A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexat…
    Ayman El-Sheikh
  19. Cognitive and Psychiatric Functioning in Adults with Carcinoid Tumors
    Susan Schultz
  20. Phase III trial of enzalutamide (NSC # 766085) versus enzalutamide, abiraterone and prednisone for castration resistant metastatic prostate cancer
    Daniel Vaena

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.